Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04727281
Other study ID # Dialysis Recovery Time
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2021
Est. completion date September 15, 2021

Study information

Verified date April 2022
Source Alexandria University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to identify factors affecting dialysis recovery time and the relation between dialysis recovery time and quality of life in hemodialysis patients.


Description:

Dialysis is defined as the diffusion of molecules in solution across a semipermeable membrane along an electrochemical concentration gradient. The primary goal of hemodialysis (HD) is to restore the intracellular and extracellular fluid environment that is characteristic of normal kidney function. In addition to diffusion, solutes may pass through pores in the membrane by means of a convective process driven by hydrostatic or osmotic pressure gradients a process called ultrafiltration. During ultrafiltration, there is no change in solute concentrations; its primary purpose is the removal of excess total body water. Fatigue is a well-known and frequent symptom in HD patients with a reported association with the decrease in health-related quality of life commonly found in this population. The prevalence of fatigue ranges from 60% to as high as 97% in patients on long-term renal replacement therapy. Despite this fact, health care providers are still unaware of both its presence and severity. The clinical assessment of fatigue in dialysis patient can be somehow difficult for the treating physicians. Patients usually show diversity in their recovery from fatigue. However, early recognition is essential because a number of treatable causes can be easily identified. Post-HD fatigue is a common incapacitating symptom affecting renal population. It is defined as a feeling of exhaustion that regularly follows each dialysis procedure. Uremia-related factors such as anemia, nutritional deficiency and enhanced inflammatory state could possibly lead to post-HD fatigue. In addition, the HD procedure itself including the efficiency of HD session, type of dialyzer and ultrafiltration rate are potential exacerbating factors for post-HD fatigue. Several methods have been proposed as a way to assess post-HD fatigue with the "time to recover (minutes) from HD" being one of them. Lindsay et al. assisted patients' responses to the single open-ended question, "How long does it take you to recover from a dialysis session?".Lindsay et al. found that post hemodialysis recovery time is an important indicator for patients' quality of life. Health-related quality of life (HRQOL) is a critically important outcome for patients with end-stage renal disease (ESRD). The National Quality Forum selected the Kidney Disease Quality of Life Short-Form survey (KDQOL™-36) as the tool of choice for assessing this outcome in adult patients with ESRD; assessment is required within 4 months of initiating dialysis, and annually thereafter. This 36-question survey instrument was published in 2000. The KDQOL™-36 contains 5 subscales: the Physical Component Summary(PCS), Mental Component Summary (MCS), Burden of Kidney Disease (BKD), Symptoms and Problems of Kidney Disease (SPKD), and Effects of Kidney Disease (EKD). The first 2 subscales are a general measure of HRQOL, whereas the last 3 assess issues specific to patients with ESRD or earlier stages of chronic kidney disease.(15) The Kidney Disease Quality of Life Short Form 36 (KDQOL-36) provides accurate estimate for fatigue severity and was previously used in HD population. Although post-HD fatigue commonly exists in dialysis patients, it is usually underestimated by physicians. For this reason, appropriate and early identification of symptoms and associated factors might improve the patient's quality of life. Extending the research in this area will certainly be of great value to HD population.


Recruitment information / eligibility

Status Completed
Enrollment 210
Est. completion date September 15, 2021
Est. primary completion date August 15, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - End Stage renal disease patients who have been assigned to regular long-term hemodialysis and perform thrice weekly, four hours HD sessions for more than 90 days. - Patient's age of 18 years of more. They should be able to read and write, and in a complete mental health. Exclusion Criteria: - Inability to answer the questionnaires because of hearing or reading problems, dementia, actual instability of clinical conditions requiring hospitalization, liver failure, and active cancer. - Patients who experience a decline in the level of consciousness during the HD session.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Quality of life assessment using the Kidney Disease Quality of Life 36 (KDQOL-36) short form and Malnutrition-Inflammation Score
Data about nutritional status using the Malnutrition-Inflammation Score, and Quality of life assessment using the Kidney Disease Quality of Life 36 (KDQOL-36) short form. Dialysis related data, The time needed for the patient to recover from a dialysis session (in minutes), Detailed history taking, Thorough physical examination, Laboratory Investigations: • Hemoglobin , Serum sodium and potassium , Serum creatinine and blood urea , Serum phosphorus, serum calcium , Serum PTH level , Serum albumin ,CRP ,Total iron-binding capacity .

Locations

Country Name City State
Egypt Faculty of Medicine, Alexandria University Alexandria

Sponsors (1)

Lead Sponsor Collaborator
Alexandria University

Country where clinical trial is conducted

Egypt, 

References & Publications (5)

As'habi A, Tabibi H, Hedayati M, Mahdavi-Mazdeh M, Nozary-Heshmati B. Association of malnutrition-inflammation score, dialysis-malnutrition score and serum albumin with novel risk factors for cardiovascular diseases in hemodialysis patients. Ren Fail. 2015 Feb;37(1):113-6. doi: 10.3109/0886022X.2014.967615. Epub 2014 Oct 8. — View Citation

Cohen DE, Lee A, Sibbel S, Benner D, Brunelli SM, Tentori F. Use of the KDQOL-36™ for assessment of health-related quality of life among dialysis patients in the United States. BMC Nephrol. 2019 Apr 1;20(1):112. doi: 10.1186/s12882-019-1295-0. Erratum in: BMC Nephrol. 2019 Dec 10;20(1):461. — View Citation

Lindsay RM, Heidenheim PA, Nesrallah G, Garg AX, Suri R; Daily Hemodialysis Study Group London Health Sciences Centre. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. Clin J Am Soc Nephrol. 2006 Sep;1(5):952-9. Epub 2006 Jul 6. — View Citation

Rayner HC, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF, Mapes DL, Lopes AA, Gillespie BW, Hasegawa T, Saran R, Tentori F, Hecking M, Pisoni RL, Robinson BM. Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2014 Jul;64(1):86-94. doi: 10.1053/j.ajkd.2014.01.014. Epub 2014 Feb 14. — View Citation

Sakkas GK, Karatzaferi C. Hemodialysis fatigue: just "simple" fatigue or a syndrome on its own right? Front Physiol. 2012 Jul 31;3:306. doi: 10.3389/fphys.2012.00306. eCollection 2012. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary dialysis recovery time The time needed for the patient to recover from a dialysis session (in minutes). 48-72 hours
Secondary quality of life assessment Quality of life assessment using the Kidney Disease Quality of Life 36 (KDQOL-36) short form. 90 days
Secondary nutritional status Data about nutritional status using the Malnutrition-Inflammation Score 90 days
See also
  Status Clinical Trial Phase
Completed NCT06022835 - Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis N/A
Not yet recruiting NCT05939505 - The Effect of Sujok Therapy on Symptom Burden and Comfort Level in Patients Undergoing Hemodialysis Treatment N/A
Completed NCT05307601 - Immune Response Following COVID-19 in Hemodialysis Patients
Active, not recruiting NCT05287204 - Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT
Recruiting NCT06141798 - Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients N/A
Recruiting NCT04954690 - Structured Program of Exercise for Recipients of Kidney Transplantation N/A
Not yet recruiting NCT05586854 - Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia N/A
Completed NCT05382468 - Effectiveness of Intradialytic Exercise on Reduction in Fatigue and Muscle Cramps N/A
Recruiting NCT05105503 - Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System
Recruiting NCT06374537 - Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients. N/A
Not yet recruiting NCT06360302 - Plasma Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in CKD Dialysis Patients N/A
Completed NCT05564676 - Flaxseed Oil and Pomegranate Extract on Inflammation, Lipid Profile and Nutritional Status of Hemodialysis Patients N/A
Completed NCT05214872 - The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease
Not yet recruiting NCT05966116 - Sodium Accumulation Study in Haemodialysis: Brain Study
Recruiting NCT06153888 - ULtrafiltration-Rate Induced CArdiac Strain (ULRICA) - Study N/A
Completed NCT04285775 - A Novel Device for Surveillance of Vascular Access Sites for Bleeding
Not yet recruiting NCT06123806 - Factors Affecting Dialysis Associated Fatigue
Not yet recruiting NCT06446739 - LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM) N/A
Recruiting NCT05096195 - PRevEnting FracturEs in REnal Disease 1 Phase 4
Completed NCT04274556 - Recovery Time and Affecting Factors in Hemodialysis Patients